ACE2 and COVID-19: Diversified biomarkers were tested in order to ascertain their prognostic value in prediction of COVID-19 severity, among those, laboratory ones included ILs, D-dimer, and CRP, while genetic biomarkers involved TMPRSS2, SNPs in ACE2, TNF-α, and IFN-γ (111–114).